[Effects of FLAG regimen in treatment of refractory or relapsed acute myeloid leukemia]. 2005

Xiao-Xiong Wu, and Wan-Ming Da, and Hong-Hua Li, and Yu Zhao, and Quan-Shun Wang, and Shu-Hong Wang, and Hai-Yan Zhu
Department of Hematology, General Hospital of Chinese PLA, Beijing 100853, China. wuxx1963@163.com

In order to evaluate the effects of FLAG regimen in treatment of refractory and relapsed acute myeloid leukemia (AML), 27 patients with refractory or relapsed acute myeloid leukemia (10 refractory AML patients, 17 relapsed AML patients) were treated with FLAG regimen. The results show that the rate of complete remission was 48.2% (13/27), the rate of partial remission was 14.8% (4/27), and the overall response rate was 63.0%. Main toxicities were gastrointestinal side effectes, myelosupression and neutropenia. It is concluded that FLAG regimen can be employed in treatment of the refractory or relapsed patients who were not respond to other regimen, and the regiment was safe.

UI MeSH Term Description Entries
D007948 Leukemia, Monocytic, Acute An acute myeloid leukemia in which 80% or more of the leukemic cells are of monocytic lineage including monoblasts, promonocytes, and MONOCYTES. Leukemia, Monoblastic, Acute,Leukemia, Myeloid, Acute, M5,Leukemia, Myeloid, Schilling-Type,Monoblastic Leukemia, Acute,Monocytic Leukemia, Acute,Myeloid Leukemia, Acute, M5,Myeloid Leukemia, Schilling-Type,Leukemia, Acute Monocytic,Leukemia, Myeloid, Schilling Type,Acute Monoblastic Leukemia,Acute Monoblastic Leukemias,Acute Monocytic Leukemia,Acute Monocytic Leukemias,Leukemia, Schilling-Type Myeloid,Leukemias, Acute Monoblastic,Leukemias, Acute Monocytic,Monoblastic Leukemias, Acute,Monocytic Leukemias, Acute,Myeloid Leukemia, Schilling Type,Schilling-Type Myeloid Leukemia
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009325 Nausea An unpleasant sensation in the stomach usually accompanied by the urge to vomit. Common causes are early pregnancy, sea and motion sickness, emotional stress, intense pain, food poisoning, and various enteroviruses.
D009364 Neoplasm Recurrence, Local The local recurrence of a neoplasm following treatment. It arises from microscopic cells of the original neoplasm that have escaped therapeutic intervention and later become clinically visible at the original site. Local Neoplasm Recurrence,Local Neoplasm Recurrences,Locoregional Neoplasm Recurrence,Neoplasm Recurrence, Locoregional,Neoplasm Recurrences, Local,Recurrence, Local Neoplasm,Recurrence, Locoregional Neoplasm,Recurrences, Local Neoplasm,Locoregional Neoplasm Recurrences,Neoplasm Recurrences, Locoregional,Recurrences, Locoregional Neoplasm
D012141 Respiratory Tract Infections Invasion of the host RESPIRATORY SYSTEM by microorganisms, usually leading to pathological processes or diseases. Respiratory System Infections,Upper Respiratory Tract Infection,Upper Respiratory Tract Infections,Infections, Respiratory,Infections, Respiratory Tract,Infections, Upper Respiratory,Infections, Upper Respiratory Tract,Respiratory Infections,Upper Respiratory Infections,Infection, Respiratory System,Infection, Respiratory Tract,Respiratory Infection, Upper,Respiratory System Infection,Respiratory Tract Infection
D003561 Cytarabine A pyrimidine nucleoside analog that is used mainly in the treatment of leukemia, especially acute non-lymphoblastic leukemia. Cytarabine is an antimetabolite antineoplastic agent that inhibits the synthesis of DNA. Its actions are specific for the S phase of the cell cycle. It also has antiviral and immunosuppressant properties. (From Martindale, The Extra Pharmacopoeia, 30th ed, p472) Ara-C,Arabinofuranosylcytosine,Arabinosylcytosine,Cytosine Arabinoside,Aracytidine,Aracytine,Cytarabine Hydrochloride,Cytonal,Cytosar,Cytosar-U,beta-Ara C,Ara C,Arabinoside, Cytosine,Cytosar U,beta Ara C
D003967 Diarrhea An increased liquidity or decreased consistency of FECES, such as running stool. Fecal consistency is related to the ratio of water-holding capacity of insoluble solids to total water, rather than the amount of water present. Diarrhea is not hyperdefecation or increased fecal weight. Diarrheas
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Xiao-Xiong Wu, and Wan-Ming Da, and Hong-Hua Li, and Yu Zhao, and Quan-Shun Wang, and Shu-Hong Wang, and Hai-Yan Zhu
January 2011, Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi,
Xiao-Xiong Wu, and Wan-Ming Da, and Hong-Hua Li, and Yu Zhao, and Quan-Shun Wang, and Shu-Hong Wang, and Hai-Yan Zhu
April 2009, Zhongguo shi yan xue ye xue za zhi,
Xiao-Xiong Wu, and Wan-Ming Da, and Hong-Hua Li, and Yu Zhao, and Quan-Shun Wang, and Shu-Hong Wang, and Hai-Yan Zhu
March 2013, Experimental and therapeutic medicine,
Xiao-Xiong Wu, and Wan-Ming Da, and Hong-Hua Li, and Yu Zhao, and Quan-Shun Wang, and Shu-Hong Wang, and Hai-Yan Zhu
November 2017, Clinical lymphoma, myeloma & leukemia,
Xiao-Xiong Wu, and Wan-Ming Da, and Hong-Hua Li, and Yu Zhao, and Quan-Shun Wang, and Shu-Hong Wang, and Hai-Yan Zhu
April 2012, Journal of pediatric hematology/oncology,
Xiao-Xiong Wu, and Wan-Ming Da, and Hong-Hua Li, and Yu Zhao, and Quan-Shun Wang, and Shu-Hong Wang, and Hai-Yan Zhu
January 2017, [Rinsho ketsueki] The Japanese journal of clinical hematology,
Xiao-Xiong Wu, and Wan-Ming Da, and Hong-Hua Li, and Yu Zhao, and Quan-Shun Wang, and Shu-Hong Wang, and Hai-Yan Zhu
October 2003, Di 1 jun yi da xue xue bao = Academic journal of the first medical college of PLA,
Xiao-Xiong Wu, and Wan-Ming Da, and Hong-Hua Li, and Yu Zhao, and Quan-Shun Wang, and Shu-Hong Wang, and Hai-Yan Zhu
April 2003, Annals of hematology,
Xiao-Xiong Wu, and Wan-Ming Da, and Hong-Hua Li, and Yu Zhao, and Quan-Shun Wang, and Shu-Hong Wang, and Hai-Yan Zhu
March 2024, Journal of clinical medicine,
Xiao-Xiong Wu, and Wan-Ming Da, and Hong-Hua Li, and Yu Zhao, and Quan-Shun Wang, and Shu-Hong Wang, and Hai-Yan Zhu
January 2006, Annals of hematology,
Copied contents to your clipboard!